HomeInsightsStock Comparison

Alembic Pharmaceuticals Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Alembic Pharmaceuticals Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Last Updated on: Apr 27, 2025

Key Highlights

  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 875.45 as of 25 Apr 15:30.
  • The P/E Ratio of Alembic Pharmaceuticals Ltd changed from 12.1 on March 2020 to 31.4 on March 2024 . This represents a CAGR of 21.01% over 5 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10059 crore on March 2020 to ₹ 19309 crore on March 2024 . This represents a CAGR of 13.93% over 5 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Alembic Pharmaceuticals Ltd for the Dec '24 is ₹ 1702 crore as compare to the Sep '24 revenue of ₹ 1678 crore. This represent the growth of 1.44% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Alembic Pharmaceuticals Ltd for the Dec '24 is ₹ 270.08 crore as compare to the Sep '24 ebitda of ₹ 269.74 crore. This represent the growth of 0.13% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Alembic Pharmaceuticals Ltd changed from ₹ 120.6 crore to ₹ 137.7 crore over 7 quarters. This represents a CAGR of 7.87% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Alembic Pharmaceuticals Ltd changed from 19.45 % on March 2020 to 32.44 % on March 2024 . This represents a CAGR of 10.77% over 5 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.
  • As per the scheme of arrangement, the 'Pharmaceutical Undertaking' of the Alembic Ltd was demerged and transferred to the company with effect from appointed date, April 1, 2010. In April 15, 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

About Welcure Drugs & Pharmaceuticals Ltd

  • Incorporated on 4 Jun.'92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
  • The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 7-cr project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
  • The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
  • It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharmaceuticals commissions new facility at Pithampur, Madhya Pradesh

Alembic Pharmaceuticals has commissioned a new manufacturing facility located at Pithampur...

Read more

26 Apr 2025 14:24

News

Alembic Pharmaceuticals to conduct board meeting

Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 ...

Read more

19 Apr 2025 10:36

News

Alembic Pharmaceuticals receives USFDA approval for Carbamazepine Tablets

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the U...

Read more

17 Apr 2025 12:08

News

Alembic Pharma receives final approval for Carbamazepine tablets

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

17 Apr 2025 12:13

News

Alembic Pharmaceuticals receives USFDA approval for Pantoprazole sodium for injection

Alembic Pharmaceuticals has received Final Approval from the US Food & Drug Administration...

Read more

02 Apr 2025 11:16

News

Alembic Pharma receives USFDA final approval for Pantoprazole Sodium Injection

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

01 Apr 2025 13:17

Welcure Drugs & Pharmaceuticals Ltd News Hub

News

Welcure Drugs & Pharmaceuticals schedules board meeting

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

11 Feb 2025 13:48

News

Welcure Drugs & Pharmaceuticals revises board meeting date

Welcure Drugs & Pharmaceuticals has revised the meeting of the Board of Directors which wa...

Read more

14 Nov 2024 10:33

News

Welcure Drugs & Pharmaceuticals to hold board meeting

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

08 Nov 2024 17:01

News

Welcure Drugs & Pharmaceuticals to hold board meeting

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

17 Oct 2024 17:08

News

Welcure Drugs & Pharmaceuticals to convene AGM

Welcure Drugs & Pharmaceuticals announced that the Annual General Meeting (AGM) of the com...

Read more

11 Sep 2024 10:36

News

Welcure Drugs & Pharmaceuticals to conduct AGM

Welcure Drugs & Pharmaceuticals announced that the Annual General Meeting (AGM) of the com...

Read more

11 Sep 2024 10:29

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Welcure Drugs & Pharmaceuticals Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Welcure Drugs & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alembic Pharmaceuticals Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Alembic Pharmaceuticals Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Alembic Pharmaceuticals Ltd is 17,208 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 93 Cr

What are the key factors driving the stock performance of Alembic Pharmaceuticals Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Alembic Pharmaceuticals Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alembic Pharmaceuticals Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of April 27, 2025, the Alembic Pharmaceuticals Ltd stock price is INR ₹875.45. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹8.3.

How do dividend payouts of Alembic Pharmaceuticals Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Alembic Pharmaceuticals Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions